Connor, Clark & Lunn Investment Management (CC&L)’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.1M | Sell |
|
|||||
|
2025
Q1 | $4.27M | Buy |
|
|||||
|
2024
Q4 | $3.92M | Buy |
|
|||||
|
2024
Q3 | $3.66M | Buy |
|
|||||
|
2024
Q2 | $4.1M | Buy |
|
|||||
|
2024
Q1 | $2.85M | Buy |
|
|||||
|
2023
Q4 | $1.12M | Hold |
|
|||||
|
2023
Q3 | $1.15M | Hold |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Buy |
|
|||||
|
2022
Q4 | $1.62M | Buy |
|
|||||
|
2022
Q3 | $1.18M | Buy |
|
|||||
|
2022
Q2 | $758K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $484K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $212K | Sell |
|
|||||
|
2015
Q4 | $782K | Sell |
|
|||||
|
2015
Q3 | $1.01M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $176K | Sell |
|
|||||
|
2014
Q4 | $514K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $2.6M | Buy |
|
|||||
|
2013
Q4 | $999K | Buy |
|
|||||
|
2013
Q3 | $768K | Buy |
|
|||||
|
2013
Q2 | $203K | Buy |
|